In morning trading, Visteon shares rose 30 cents, or 6.4 percent, to $4.99, after peaking at $5.10 earlier in the day. In the past 52 weeks, Visteon shares have traded between $4.56 and $10.14.

Robert Barry of Goldman Sachs removed Visteon from the investment bank's Americas "Sell" list and gave it a "Neutral" rating saying skepticism about the plan is reflected in the stock price.

"Concerns about the U.S. economy and investor risk aversion likely persist, but increased investor skepticism around a Visteon restructuring that we feel is now factored into the stock should limit further downside," Barry wrote in a note to investors.

Still, Barry emphasized that Visteon's turnaround still remains uncertain. While the company's savings could speed up in 2008 with the scheduled closures of two plants, North American volume and cash flow problems are expected to persist, he said.

"Buying into a Visteon restructuring story at the now depressed level, investors are getting paid to hold the shares through a more risky U.S. macro environment until traction on the restructuring accelerates, which we expect to occur in early 2008," Barry wrote.